“…From a public health perspective, the latter scenario, based on a USD 2.9bn real GDP loss and 13,621 person-years saved, suggests a cost-effectiveness ratio of >USD 200,000 per person-year saved. This exceeds standard cost-effectiveness thresholds for healthcare interventions in developed countries by an order of magnitude (and for developing countries by even more), and, since strong regulation to curb the growth of palm oil is not on the horizon and strategic rebalancing towards the use of palm oil for biofuels and oleochemicals can only be envisaged in the long term (Shankar et al, 2017), it may be worth investigating other behavioural interventions, as well as non-behavioural non-lifestyle interventions, which may compare favourably to this scenario and be more effective in addressing CVD-illness in Thailand. Non-pecuniary valuation of long run GHG emission reduction benefits according to World Bank Guidelines (WB, 2017) would not change this conclusion.…”